Dosage Information for Xofigo: Form, Potency, Administration Method, and Additional Details
In the realm of advanced prostate cancer treatment, a notable option is Xofigo (radium-223), a bone-targeted radiation therapy designed specifically for cases where the cancer has spread to the bones but not to other organs.
This treatment is recommended for patients whose hormone therapy has lost effectiveness and who have either received or are unsuitable for the chemotherapy drug docetaxel. Xofigo selectively targets bone metastases by mimicking calcium uptake, delivering localized radiation to cancer cells with minimal exposure to healthy tissue.
The typical dosage and administration method for Xofigo in adults with advanced prostate cancer is an intravenous injection, given once every four weeks, usually for up to six doses. Each injection takes about one minute to administer in a nuclear medicine or radiation oncology department.
Patients receiving Xofigo treatment undergo regular safety and treatment effect monitoring, typically through blood tests between treatments. Given its radioactive nature, administration is carried out under controlled clinical conditions.
The recommended regimen for Xofigo is as follows: - Dose: Radium-223 injection (Xofigo) - Frequency: Every four weeks - Duration: Up to six injections total - Route: Intravenous injection in a medical facility
Clinical trials have demonstrated improvement in symptoms and overall survival for men with metastatic castration-resistant prostate cancer limited to bone involvement.
It's important to note that the dosage of Xofigo may vary based on your doctor's recommendation. For questions about the dosage that's best for you, consult your doctor.
The injection site for Xofigo is a qualified treatment facility, which your doctor or healthcare professional can help you locate. In the event of a missed injection, call your doctor's office to reschedule.
Xofigo starts working right away after administration. For additional information about Xofigo, refer to specific articles on Medical News Today. For details about prostate cancer, see the cancer hub on Medical News Today.
It's worth mentioning that Xofigo comes as an injectable solution, whereas Xtandi, another prostate cancer treatment, comes as oral capsules and oral tablets. The dosages for each drug differ because they have different active ingredients, formulations, and ways they work.
Remember, this article is intended to provide general information about Xofigo. Always consult with a healthcare professional for personalised advice and guidance.
In the realm of health-and-wellness, Xofigo is a medical-condition-specific therapy and treatment option for advanced prostate cancer patients with metastatic castration-resistant prostate cancer limited to bone involvement. This radiation therapy, targeted at bone metastases, uses science to mimic calcium uptake, delivering localized radiation to cancer cells with minimal exposure to healthy tissue.
